HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) SHH

8.01

-0.09(-1.11%)

Updated at October 17 03:00PM

Currency In CNY

Valuation

Market Cap4.35B
Enterprise Value4.12B
P/E Ratio30.81
PEG Ratio-1.91
Price/Sales Ratio0.45
Price/Book Ratio1.57
Enterprise/Revenue0.44
Enterprise/EBITDA19.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue10.05B
Revenue/Share17.62
Gross Profit867.38M
EBITDA319.08M
Net Income213.27M
Diluted EPS0.37

Balance Sheet

Total Cash876.31M
Total Cash/Share1.51
Total Debt773.75M
Total Debt/Equity0.26
Current Ratio1.67
Book Value Per Share5.1

Price History

52-Week Change35.76
52-Week High11.28
52-Week Low5.84
Moving Average 50 Days8.16
Moving Average 200 Days7.81

Statistics

Average Volume14.81M
Shares Outstanding579.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.71
Last Split Factor3:2
Last Split DateJune 14, 2011